← Open Payments lookup

CAIN SCHEXNEIDER: Open Payments

NPI 1588147276 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$703 in 42 payments from 13 companies in 2025. Trend: 2023 $466 · 2024 $444 · 2025 $703

Food & beverage: $703
CompanyPaymentsAmount
ABBVIE INC.15$199
Vanda Pharmaceuticals Inc.9$136
Axsome Therapeutics, Inc.4$83
Alkermes, Inc.3$55
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$52
Supernus Pharmaceuticals, Inc.2$40
Takeda Pharmaceuticals U.S.A., Inc.1$26
Janssen Pharmaceuticals, Inc1$23
Corium, LLC1$20
Collegium Pharmaceutical, Inc.1$18

Products named: VRAYLAR, FANAPT, Auvelity, ARISTADA, CAPLYTA, Qelbree, TRINTELLIX, SPRAVATO.

Industry payments across LA — which companies pay providers there.